Suppr超能文献

术后肺血栓栓塞可能与重组活化凝血因子VII输注治疗椎体器械固定术中难以控制的出血有关。

Postoperative pulmonary thromboembolism possibly associated with recombinant activated factor VII infusion for the treatment of uncontrolled hemorrhage during vertebral instrumentation.

作者信息

Khan Zahid Hussain, Soltani Alireza Ebrahim, Rahmani Payman

机构信息

Deptartment of Anesthesiology, Imam Khomeini Medical Center, Tehran University of Medical Sciences, Keshavarz Blvd., Tehran 14197, Iran.

出版信息

J Anesth. 2007;21(2):258-60. doi: 10.1007/s00540-006-0481-y. Epub 2007 May 30.

Abstract

We report the successful use of recombinant activated factor VII (rFVIIa) infusion in an 18-year-old man who underwent L3 laminectomy and pedicular screw fixation with severe refractory bleeding secondary to severe coagulopathy, which had remained unresponsive to conventional medical and surgical therapies. However, the patient developed a thromboembolic complication presumably associated with the use of rFVIIa. Although rFVIIa provides a dramatic response in intractable bleeding, it may cause a thromboembolic phenomenon which should be vigilantly considered and promptly treated.

摘要

我们报告了重组活化凝血因子 VII(rFVIIa)成功用于一名 18 岁男性的案例。该患者接受了 L3 椎板切除术和椎弓根螺钉固定术,因严重凝血障碍导致严重难治性出血,对传统药物和手术治疗均无反应。然而,患者出现了可能与使用 rFVIIa 相关的血栓栓塞并发症。尽管 rFVIIa 在难治性出血中能产生显著效果,但它可能会引起血栓栓塞现象,对此应予以警惕并及时治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验